Consequently, relevant differences may have remained undetected, and borderline significant findings—particularly the etiology-dependent association between IL-38 and AST [ 40 ]—should be interpreted with caution and validated in larger, adequately powered cohorts.
← all excerpts
Interleukin-38: A Candidate Biomarker for Disease Severity in Advanced Steatotic Liver Disease.
1
—
—